A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY

Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Acta Endocrinol (Buchar)
Huvudupphovsmän: Aydin, B., Aksu, O., Asci, H., Kayan, M., Korkmaz, H.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Acta Endocrinologica Foundation 2018
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/
https://ncbi.nlm.nih.gov/pubmed/31149244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk